New insights in biologically active proteins and peptides derived from hen egg

World's Poultry Science Journal

Volumn 62, Issue 1, 2006, Pages

  Mine, Y ^a   Kovacs Nolan, J ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Bioactive peptides; Chronic disease; Egg proteins; Hen; Human health; Nutraceuticals

Indexed keywords

ANIMALIA;

EID: 33645501006     PISSN: 00439339     EISSN: None     Source Type: Journal    
DOI: 10.1079/WPS200586     Document Type: Review

References (76)

1. ABDALLAH, F.B. and CHAHINE, J.M. (1999) Transferrins, the mechanism of iron release by ovotransferrin. European Journal of Biochemistry 263: 912-920.
2. AGUILERA, O., QUIROS, L.M. and FIERRO, J.F. (2003) Transferrins selectively cause ion efflux through bacterial and artificial membranes. FEBS Letter 548: 5-10.
3. ASAKURA, K., KOJIMA, T., SHIRASAKI, H. and KATAURA, A. (1990) Evaluation of the effects of antigen specific immunotherapy on chronic sinusitis in children with allergy. Auris Nasus Larynx 17: 33-38.
4. BANKS, J.G., BOARD, R.G. and SPARKS, N.H.C, (1986) Natural antimicrobial systems and their potential in food preservation of the future. Biotechnology and Applied Biochemistry 8: 103-147.
5. BARON, F., FAUVEL, S. and GAUTIER, M. (2000) Behaviour of Salmonella enteritidis in industrial egg white: egg naturally contains factors inhibitory to salmonella growth. In: Egg Nutrition and Biotechnology; Sim, J. S.; Nakai, N.; Guenter, W., Eds; CAB International: Oxon, UK, pp. 417-430.
6. BRADY, D., GAINES, S., FENELON, L., MCPARTLIN J. and O'FARRELLY, C.A. (2002) A lipoprotein-derived antimicrobial factor from hen-egg yolk is active against Streptococcus species. Journal of Food Science 67: 3096-3103.
7. BURLEY, R.W. and VADEHRA, D.V. (1989) The Avian Egg, Chemistry and Biology. John Wiley & Sons, Inc.: New York, New York.
8. BURLEY, R.W. and COOK, W.H. (1961) Isolation and composition of avian egg yolk granules and their constituents α- and β-lipovitellines. Canadian Journal of Biochemical Physiology 39: 1295-1307.
9. BRADY, D., GAINES, S., FENELON, L., MCPARTLIN, J. and O'FARRELLY, C.A. (2002) A lipoprotein-derived antimicrobial factor from hen-egg yolk is active against Streptococcus species. Journal of Food Science 67: 3096-3103.
10. CARLANDER, D., KOLLBERG, H., WEJAKER, P.E. and LARSSON, A. (2000) Peroral immunotherapy with yolk antibodies for the prevention and treatment of enteric infections. Immunology Research 21: 1-6.
11. CHOI, I., JUNG, C., SEOG, H. and CHOI, H. (2004) Purification of phosvitin from egg yolk and determination of its physiochemical properties. Food Science and Biotechnology 13: 434-437.
12. COTTERDLL, O.J. and GEIGER, G.S. (1977) Egg product yield trends from shell eggs. Poultry Science 56: 1027-1031.
13. DAS, S., BANERJEE, S. and GUPTA, J.D. (1992) Experimental evaluation of preventative and therapeutic potential of lysozyme. Chemotherapy 38: 350-357.
14. DAVALOS, A., MIGUEL, M., BARTOLOME, B. and LOPEZ-FINDINO, R. (2004) Antioxidant activity of peptides derived from egg white proteins by enzymatic hydrolysis. Journal of Food Protection 67: 1939-1944.
15. FAN, X., SUBRAMANIAM, R., WEISSM, M.F. and MONNIER, V.M. (2003) Methylglyoxal-bovine serum albumin stimulates tumor necrosis factor alpha secretion in RAW 264.7 cells through activation of mitogen-activating protein kinase, nuclear factor kappaB and intracellular reactive oxygen species formation. Archives of Biochemistry and Biophysics 409: 274-286.
16. FUJITA, H., SASAKI, R. and YOSHIKAWA, M. (1995a) Potentiation of the antihypertensive activity of orally administered ovokinin, a vasorelaxing peptide derived from ovalbumin, by emulsification in egg phosphatidylcholine. Bioscience Biotechnology and Biochemistry 59: 2344-2345.
17. FUJITA, H., USUI, H., KURAHASHI, K. and YOSHIKAWA, M. (1995b) Isolation and characterization of ovokinin, a bradykinin B1 agonist peptide derived from ovalbumin. Peptides 16: 785-790.
18. GIANSANTI, F., ROSSI, P. MASSUCCI M.T., BOTTI, D., ANTONINI, G., VALENTI, P. and SEGANTI, L. (2002) Antiviral activity of ovotransferrin discloses an evolutionary strategy for the defensive activities of lactoferrin. Biochemistry and cell biology 80: 125-130.
19. GOLDBERG, J., SHRIKANT, P. and MESCHER, M.F. (2003) In vivo augmentation of tumor-specific CTL responses by class I/peptide antigen complexes on microspheres (large multivalent immunogen). Journal of Immunology 170: 228-235.
20. HATTA, H., TSUDA, K., OZEKI, M., KIM, M., YAMAMOTO, T., OTAKE, S., HOROSAWA, M., KATZ, J., CHILDERS, N.K. and MICHALEK, S.M. (1997) Passive immunization against dental plaque formation in humans: Effect of a mouth rinse containing egg yolk antibodies (IgY) specific to Streptococcus mutans. Caries Research 31: 268-274.
21. HE, X., TSANG, T.C., LUO, P., ZHANG, T. and HARRIS, D.T. (2003) Enhanced tumor immunogenicity through coupling cytokine expression with antigen presentation. Cancer Gene Therapy 10: 669-677.
22. HIROTA, Y., YANG, M.P., ARAKI, S., YOSHIHARA, K., FURUSAWA, S., YASUDA, M., MOHAMED, A., MATSUMOTO, Y. and ONODERA, T. (1995) Enhancing effects of chicken egg white derivatives on the phagocytic response in the dog. Journal of Veterinary Medical Science 57: 825-829.
23. HOLEN, E., BOLANN, B. and ELSAYED, S. (2001) Novel B and T cell epitopes of chicken ovomucoid (Gal d 1) induce T cell secretion of EL-6, IL-13, and IFN-gamma. Clinical Experimental Allergy 31: 952-964.
24. HORIE, K., HORIE, N., ABDOU, A.M., YANG, J-O, YUN, S.S., CHUN, C.K., KIM, M. and HATTA, H. (2004) Suppressive effect of functional drinking yogurt containing specific egg yolk immunoglobulin on Helicobacter pylori in humans. Journal of Dairy Science 87: 4703-4079.
25. IBRAHIM, H.R., SUGIMOTO, Y. and AOKI, T. (2000) Ovotransferrin antimicrobial peptide (OTAP-92) kills bacteria through a membrane damage mechanism. Biochimica et Biophysica Acta 1523: 196-205.
26. IBRAHIM, H.R., THOMAS, U. and PELLEGRINI, A. (2001) A helix-loop peptide at the upper lip of the active site cleft of lysozyme confers potent antimicrobial activity with membrane permeabilization action. Journal of Biological Chemistry 276: 43767-43774.
27. ISHIKAWA, S., YANO, Y., ARIHARA, K. and ITOH, M. (2004) Egg yolk phosvitin inhibits hydroxyl radical formation from the Fenton reaction. Bioscience Biotechnology and Biochemistry 68: 1324-1331.
28. JIANG, B. and MINE, Y. (2000) Preparation of novel functional oligophosphopeptides from hen egg yolk phosvitin. Journal of Agricultural Food Chemistry 48: 990-994.
29. JIANG, B. and MINE, Y. (2001) Phosphopeptides derived from hen egg yolk phosvitin: effect of molecular size on the calcium-binding properties. Bioscience Biotechnology and Biochemistry 65: 1187-1190.
30. KASSAIFY, Z.G. and MINE, Y. (2004a) Non-immunized egg yolk powder can suppress the colonization of Salmonella typhimurium, E. coli 0157:H7 and Campylobacter jejuni in laying hens. Poultry Science 83: 1497-1506.
31. KASSAIFY, Z.G., Li, E.W.Y. and MINE, Y. (2005) Identification of antiadhesive fractions in nonimmunized egg yolk powder: In vitro study. Journal of Agricultural Food Chemistry 53: 4607-4614.
32. KASSAIFY, Z.G. and MINE, Y. (2004b) Effect of food protein supplements on Salmonella enteritidis infection and prevention in laying hens. Poultry Science 83: 753-760.
33. KATO, T., IMATANI, T., MIURA, T., MINAGUCHI, K., SAITOH, E. and OKUDA, K. (2000) Cytokine-inducing activity of family 2 cystatins. Biological Chemistry 381: 1143-1147.
34. KOBAYASHI, K., HATTORI, M., HARA-KUDO, Y., OKUBO, T., YAMAMOTO, S., TAKITA, T. and SUGITA-KONISHI, Y. (2004) Glycopeptide derived from hen egg ovomucin has the ability to bind enterohemorrhagic Escherichia coli O157:H7. Journal of Agricultural Food Chemistry 52: 5740-5746.
35. KOLLBERG, H., CARLANDER, D., OLESEN, H., WEJAKER, P.E., JOHANNESSON, M. and LARSSON, A. (2003) Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis: A phase I feasibility study. Pediatric pulmonology 35: 433-440.
36. KORPELA, J., SALONEN, E.M., KUUSELA, P., SARVAS, M. and VAHERI, A. (1984) Binding of avidin to bacteria and to the outer membrane porin of Escherichia coli. FEMS Microbiological Letter 22: 3-10.
37. KOVACS-NOLAN, J. and MINE, Y. (2004) Avian egg antibodies: Basic and potential applications. Avian Poultry Biology Review 15: 25-46.
38. KRUGER, C., PEARSON, S.K., KODAMA, Y., VACCA SIMITH, A., BOWEN, W.H. and HAMMARSTRON, L. (2004) The effects of egg-derived antibodies to glucotransferases on dental caries in rats. Caries Research 38: 9-14.
39. LEE-HUANG, S., HUANG, P.L., SUN, Y., HUANG, P.L., KUMG, H.F., BITHE, D.L. and CHEN, B.C. (1999) Lysozyme and RNases as anti-HIV components in beta-core preparations of human chorionic gonadotropin. Proceedings of the National Academy of Sciences of the United States of America 96: 2678-2681.
40. LI-CHAN, E. and NAKAI, S. (1989) Biochemical basis for the properties of egg white. Critical Review of Poultry Biology 2: 21-58.
41. LI-CHAN, E., POWRIE, W.D. and NAKAI, S. (1995) The Chemistry of eggs and egg products. In: Egg Science and Technology, 4th Edition; Stadelman, W. J.; Cotterill, O. J., Eds.; The Haworth Press, Inc.: New York, New York, pp. 105-175.
42. LOSSO, J.N., NAKAI, S. and CHARTER, E.A. (2000) Lysozyme. In: Natural Food Antimicrobial Systems; Naidu, A. S., Ed.; CRC Press, Inc.: New York, New York, pp. 185-210.
43. LU, C.L. and BAKER, R. (1986) Characteristics of egg yolk phosvitin as an antioxidant for inhibiting metal-catalyzed phospholipid oxidations. Poultry Science 65: 2065-2070.
44. MATOBA, N., USUI, H., FUJITA, H. and YOSHIKAWA, M. (1999) A novel anti-hypertensive peptide derived from ovalbumin induces nitric oxide-mediated vasorelaxation in an isolated SHR mesenteric artery. FEBS Letter 452: 181-184.
45. MATOBA, N., YAMADA, Y., USUI, H., NAKAGIRI, R. and YOSHIKAWA, M. (2001) Designing potent derivatives of ovokinin(2-7), an anti-hypertensive peptide derived from ovalbumin. Bioscience Biotechnology and Biochemistry 65: 736-739.
46. MIGUEL, M., RECIO, I., GOMEZ-RUIZ, J.A., RAMOS, M. and LOPEZ-FANDINO, R. (2004) Angiotensin I-converting enzyme inhibitory activity of peptides derived from egg white proteins by enzymatic hydrolysis. Journal of Food Protection 67: 1914-1920.
47. MINE, Y., MA, F. and LAURIAU, S. (2004) Antimicrobial peptides released by enzymatic hydrolysis of hen egg white lysozyme. Journal of Agriculture and Food Chemistry 52: 1088-1094.
48. NAGAOKA, S., MASAOKA, M., ZHANG, Q., HASEGAWA, M. and WATANABE, K. (2002) Egg ovomucin attenuates hypercholesterolemia in rats and inhibits cholesterol absorption in Caco-2 cells. Lipids 37: 267-272.
49. OGURO, T., OHAKI, Y., ASANO, G., EBINA, T. and WATANABE, K. (2001) Ultrastructural and immunohistochemical characterization on the effect of ovomucin in tumor angiogenesis. Japanese Journal of Clinical Electron Microscopy 33: 89-99.
50. OTANI, H. and ODASHIMA, M. (1997) Inhibition of proliferative responses of mouse spleen lymphocytes by lacto- and ovotransferrins. Food Agriculture and Immunology 9: 193-202.
51. PACOR, S., GAGLIARD, R., DI DANIEL, E., VADORI, M. and SAVA, G. (1999) In vitro down regulation of ICAM-1 and E-cadherin and in vitro reduction of lung metastases of TS/A adenocarcinoma by a lysozyme derivative. International of Journal Molecular Medecine 4: 369-375.
52. PELLERGRINI, A., THOMAS, U., BRAMAZ, N., KLAUSER, S., HUNZIKER, P. and VON FELLENBERG, R. (1997) Identification and isolation of a bactericidal domain in chicken egg white lysozyme. Journal of Applied Microbiology 82: 372-378.
53. PELLERGRINI, A., THOMAS, U., WILD, P., SCHRANER, E. and VON FELLENBERG, R. (2000) Effect of lysozyme or modified lysozyme fragments on DNA and RNA synthesis and membrane permeability of Escherichia coli. Microbiology Research 155: 69-77.
54. PELLERGRINI, A., HULSMEIER, A., HUNZIKER, P. and THOMAS, U. (2004) Proteolytic fragments of ovalbumin display antimicrobial activity. Biochimica et Biophysica Acta 1672: 76-85.
55. SAVA, G., CESCHIA, V., PACOR, S. and ZABUCCHI, G. (1991) Observations on the antimetastatic action of lysozyme in mice bearing Lewis lung carcinoma. Anticancer Research 11: 1109-1113.
56. SAVA, G., PACOR, S., DASIC, G. and BERGAMO, A. (1995) Lysozyme stimulates lymphocyte response to ConA and IL-2 and potentiates 5-fluorouracil action on advanced carcinomas. Anticancer Research 15: 1883-1888.
57. SAVA, G. (1996) Pharmacological aspects and therapeutic applications of lysozymes. Experimental Science 75: 433-449.
58. SHARON, N. and OFEK, I. (2002) Fighting infectious diseases with inhibitors of microbial adhesion to host tissues. Critical Review of Food Science and Nutrition 42: 267-272.
59. SMITH, D.J., KING, W.F. and GODISKA, R. (2001) Passive transfer of immunoglobulin Y to Streptococcus mutans glucan binding protein B can confer protection against experimental dental caries. Infection and Immunity 69: 3135-3142.
60. SUGAHARA, T., MURAKAMI, F., YAMADA, Y. and SASAKI, T. (2000) The mode of actions of lysozyme as an immunoglobulin production stimulating factor. Biochimica et Biophysica Acta 1475: 27-34.
61. SUGINO, H., NITODA, T. and JUNEJA, L.R. (1997) General chemical composition of hen eggs. In: Hen Eggs, Their Basic and Applied Science; Yamamoto, T.; Juneja, L. R.; Hatta, H.; Kim, M., Eds.; CRC Press, Inc.: New York, New York, pp. 13-24.
62. TANIZAKI, H., TANAKA, H., IWATA, H. and KATO, A. (1997) Activation of macrophages by sulfated glycopeptides in ovomucin, yolk membrane, and chalazae in chicken eggs. Bioscience, Biotechnology and Biochemistry 61: 1883-1889.
63. TEZUKA, H. and YOSHIKAWA, M. (1995) Abstract of Annual Meeting of Japan Society for Bioscience, Biotechnology, and Agrochemistry, Tokyo, pp 163.
64. TSUGE, Y., SHIMOYAMADA, M. and WATANABE, K. (1996a) Binding of egg white proteins to viruses. Bioscience, Biotechnology and Biochemistry 60: 1503-1504.
65. TSUGE, Y., SHIMOYAMADA, M. and WATANABE, K. (1996b) Differences in hemagglutination inhibition activity against bovine rotavirus and hen newcastle disease virus based on the subunits in hen egg white ovomucin. Bioscience, Biotechnology and Biochemistry 60: 1505-1506.
66. TSUGE, Y., SHIMOYAMADA, M. and WATANABE, K. (1997a) Structural features of newcastle disease virus- and anti-ovomucin antibody-binding glycopeptides from pronase-treated ovomucin. Journal of Agriculture and Food Chemistry 45: 2393-2398.
67. TSUGE, Y., SHIMOYAMADA, M. and WATANABE, K. (1997b) Bindings of ovomucin to newcastle disease virus and anti-ovomucin antibodies and its heat stability based on binding abilities. Journal of Agriculture and Food Chemistry 45: 4629-4634.
68. VALENTI, P., ANTONINI, G., VON HUNOLSTEIN, C., VISCA, P., ORSI, N. and ANTONINI, E. (1983) Studies of the antimicrobial activity of ovotransferrin. International Journal of Tissue Research 5: 97-105.
69. VERDOT, L., LALMANACH, G., VERCRUYSSE, V., HARTMANN, S., LUCIUS, R., HOEBEKE, J., GAUTHIER, F. and VRAY, B. (1996) Cystatins up-regulate nitric oxide release from interferon-gamma-activated mouse peritoneal macrophages. Journal of Biological Chemistry 271: 28077-28081.
70. VERDOT, L., LALMANACH, G., VERCRUYSSE, V., HOEBEKE, J., GAUTHIER, F. and VRAY, B. (1999) Chicken cystatin stimulates nitric oxide release from interferon-gamma-activated mouse peritoneal macrophages via cytokine synthesis. European Journal of Biochemistry 266: 1111-1117.
71. VIDOVIC, D., GRADDIS, T., CHEN, F., SLAGLE, P., DIEGEL, M., STEPAN, L. and LAUS, R. (2002) Antitumor vaccination with HER-2-derived recombinant antigens. International Journal of Cancer 102: 660-664.
72. WAHN, V. (2003) Primary immunodeficiencies caused by defects of cytokines and cytokine receptors. In: Methods in Molecular Biology: Cytokines and Colony Stimulating Factors: Methods and Protocols; Korholz, D.; Kiess, W., Eds.; Humana Press Inc.: Totowa, New Jersey, Vol. 215, pp. 3-12.
73. WATANABE, K., YSUGE, Y., SHIMOYAMADA, M., OGAMA, N. and EBINA, T. (1998) Antitumor effects of pronase-treated fragments, glycopeptides, from ovomucin in hen egg white in a double grafted tumor system. Journal of Agriculture and Food Chemistry 46: 3033-3038.
74. XIE, H., HUFF, G.R., HUFF, W.E., BALOG, J.M. and RATH, N.C. (2002) Effects of ovotransferrin on chicken macrophages and heterophil-granulocytes. Developmental and Comparative Immunology 26: 805-815.
75. YAMADA, Y., MATOBA, N., USUI, H., ONISHI, K. and YOSHIKAWA, M. (2002) Design of a highly potent anti-hypertensive peptide based on ovokinin(2-7). Bioscience, Biotechnology and Biochemistry 66: 1213-1217.
76. YOSHIKAWA, M. and FUJITA, H. (1994) Studies on the optimum conditions to utilize biologically active peptides derived from food proteins. In: Developments in Food Engineering; Yano, T; Matsuno, R.; Nakamura, K., Eds.; Blackie Academic and Professional: New York, New York, pp. 1053-1055.